Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

BACKGROUND: Although previous studies have evaluated the effect of anti-VEGF therapies for central retinal vein occlusion (CRVO) patients, the majority of previous studies have excluded or included a very small number of patients with ischemic CRVO (iCRVO). The aim of our study is to examine the eff...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Retina Vitreous
Glavni autori: Hall, Leangelo, Frizzera, Luma Paiva, Coelho, Laura Fernandes, Carricondo, Pedro Carlos, Oyamada, Maria Kiyoko, Pimentel, Sergio Luis Gianotti, Abalem, Maria Fernanda
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6659291/
https://ncbi.nlm.nih.gov/pubmed/31372240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-019-0183-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items